Table 1. Main characters of studies included in this meta-analysis.
First author | Year | Country | Ethnicity | Control source | Sample size cases/controls | Cases | Controls | Genotype methods | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LL | LS | SS | LL | LS | SS | ||||||||
Janssen et al. | 2009 | Netherlands | Caucasian | HB | 89/92 | 27 | 43 | 19 | 27 | 41 | 24 | PCR-RFLP | |
Ozbek et al. | 2009 | Turkey | Caucasian | PB | 69/69 | 11 | 21 | 37 | 12 | 37 | 20 | PCR-RFLP | |
Safarinejad et al. | 2009 | Iran | Caucasian | PB | 82/82 | 24 | 29 | 29 | 35 | 30 | 17 | PCR-RFLP | |
Luo et al. | 2011 | China | Asian | HB | 119/90 | 24 | 34 | 61 | 25 | 31 | 34 | PCR-RFLP | |
Zuccarello et al. | 2012 | Italy | Caucasian | PB | 89/100 | 22 | 49 | 18 | 33 | 51 | 16 | PCR-RFLP | |
Huang et al. | 2016 | China | Asian | PB | 114/101 | 18 | 61 | 35 | 22 | 48 | 31 | PCR-RFLP | |
Salem et al. | 2017 | Egypt | African | HB | 60/20 | 16 | 25 | 19 | 10 | 8 | 2 | PCR-RFLP | |
Kham et al. | 2018 | Pakistan | Asian | PB | 271/152 | 108 | 97 | 66 | 30 | 72 | 50 | PCR-RFLP |
HB, hospital based; PB, population based; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism.